Back to top

Kamada Showcases New CYTOGAM Data from 2026 ISHLT Meeting, Signaling Potential Uptick in Transplant Use

Kamada ( ($IL:KMDA) ) just unveiled an update. Kamada Ltd., a leader in specialty plasma-derived therapies for rare and serious conditions, has bui...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: